Skip to main content
SpringerLink
Log in

Antiarrhythmic agents — 1987

  • Chapter
Electrocardiography and Cardiac Drug Therapy

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 92))

  • 60 Accesses

Abstract

The drug therapy of arrhythmias has developed rapidly over the last 25 years. During this period, the number of available antiarrhythmic agents has increased dramatically and many more compounds are in development. In the United Kingdom there are more than forty antiarrhythmic drugs (including beta adrenergic blocking agents) currently listed in the pharmacopoeia. This chapter will describe some aspects of newly introduced antiarrhythmic agents and methods of assessing the efficacy of drug therapy, with particular reference to the arrhythmogenic effects of drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Koster RW, Dunning AJ (1985) Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 313:1105–1110

    Article  PubMed  CAS  Google Scholar 

  2. DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68:1254–1263

    Article  PubMed  CAS  Google Scholar 

  3. Munoz A, Leenhardt A, Sassine A, Galley P, Puech P (1984) Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. Eur Heart J. 5:735–738

    PubMed  CAS  Google Scholar 

  4. Clarke B, Till J, Rowland E, Ward DE, Barnes PJ, Shinebourne EA (1987) Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet i:299–301

    Article  Google Scholar 

  5. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM (1983) Kinetics of esmolol, an ultra-short-acting beta-blocker, and of its major metabolite. Clin Pharmacol Ther 34:427–434

    Article  PubMed  CAS  Google Scholar 

  6. Steinberg JS, Katz RJ, Somberg JC, Keefe D, Laddu AR, Burge J (1986) Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol 58:1005–1008

    Article  PubMed  CAS  Google Scholar 

  7. Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM (1985) Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol 5:1451–1456

    Article  PubMed  CAS  Google Scholar 

  8. Esmolol vs Placebo Multicenter Study Group, 1986. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. Am Heart J 111:42–48

    Article  Google Scholar 

  9. Byrd RC, Sung RJ, Marks J, Parmley WW (1984) Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias. J Am Coll Cardiol 3:394–399

    Article  PubMed  CAS  Google Scholar 

  10. Esmolol Research Group (1986) Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, base-line controlled safety and efficacy study in 160 patients. Am Heart J 112:498–505

    Article  Google Scholar 

  11. Esmolol Multicenter Study Research Group (1985) Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double- blind clinical trial. Am Heart J 110:913–922

    Article  Google Scholar 

  12. Webb SC, Hendry WG, Bloom SR, Krikler DM (1986) Somatostatin: a neuroregulatory peptide with electrophysiological activity. Brit Heart J 55:513

    Article  Google Scholar 

  13. Toivonen LK, Nieminen MS, Manninen V, Frick MH (1985) Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes. Eur Heart J 6:737–744

    PubMed  CAS  Google Scholar 

  14. Toivonen LK, Nieminen MS, Manninen V, Frick MH (1986) Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study. J Cardiovasc Pharmacol 8:156–160

    Article  PubMed  CAS  Google Scholar 

  15. Wasty N, Saksena S, Barr MJ (1985) Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study. Am Heart J 110:1181–1188

    Article  PubMed  CAS  Google Scholar 

  16. Touboul P (1985) Cibenzoline. Arch Mai Coeur 78:91–94.

    Google Scholar 

  17. Somberg J, Torres V, Flowers D, Miura D, Butler B, Gottlieb S (1985) Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J 109:19–27

    Article  PubMed  CAS  Google Scholar 

  18. Anastasiou-Nana MI, Anderson JL, Hampton EM, Nanas JN, Heath BM (1986) Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias. J Am Coll Cardiol 8:427–435.

    Article  PubMed  CAS  Google Scholar 

  19. Munoz A, Aliot E, Prestat MP, Toussain P, Gagnol JP, Gilgenkrantz JM (1986) Cardiac electrophysiologic and antiarrhythmic effects of penticainide (CM 7857). Proceedings of X World Congress of Cardiology, p 179

    Google Scholar 

  20. Alioi E, Khalife K, Munoz A, Zannad F, Gagnol JP, Gilgenkrantz JM (1986) Efficacy of intravenous penticainide on spontaneous and induced sustained ventricular tachycardias. Proceedings of X World Congress of Cardiology, p 114

    Google Scholar 

  21. Lynch JJ, Wilber DJ, Montgomery DG, Hsieh TM, Patterson E, Lucchesi BR (1984) Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. J Cardiovasc Pharmacol 6:1132–1141

    PubMed  CAS  Google Scholar 

  22. Taggart P, Sutton P, Donaldson R (1985) d-Sotalol: a new potent class III antiarrhythmic agent. Clinical Science 69:631–636

    PubMed  CAS  Google Scholar 

  23. Bigger JT, Woosley RL, Roden DM, Hallstrom A, Echt D, Greene L, Butler L, and CAPS investigators (1987) A placebo-controlled study of the proarrhythmic effects of class I antiarrhythmic drugs. J Am Coll Cardiol 9:245A

    Google Scholar 

  24. Woosley RL, Giardina E-G, Roden DM, Henthorn RW, Hallstrom A, and CAPS investigators (1987) Value of dose-titration in the cardiac arrhythmia pilot study (CAPS). J Am Coll Cardiol 9:70A

    Article  Google Scholar 

  25. Bigger JT (1986) Long-term continuous electrocardiographic recordings and electrophysiologic testing to select patients with ventricular arrhythmias for drug trials and to determine antiarrhythmic drug efficacy. Am J Cardiol 58:58C-65C

    Article  PubMed  Google Scholar 

  26. Wellens HJJ, Brugada P, Stevenson WG (1985) Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 72:1–7

    Article  PubMed  CAS  Google Scholar 

  27. Velebit V, Podrid PJ, Lown B, Cohen BH, Graboys TB (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886–894

    Article  PubMed  CAS  Google Scholar 

  28. Poser RF, Podrid PJ, Lombardi F, Lown B (1985) Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing. Am Heart J 110:9–16

    Article  PubMed  CAS  Google Scholar 

  29. Binder MJ, Rosove L (1952) Paroxysmal ventricular tachycardia and fibrillation due to quinidine. Am J Med 12:491–495

    Article  PubMed  CAS  Google Scholar 

  30. Meltzer RS, Robert EW, McMorrow M, Martin RP (1978) Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. Am J Cardiol 42:1049–1053

    Article  PubMed  CAS  Google Scholar 

  31. McGovern B, Garan H, Kelly E, Ruskin JN (1983) Adverse reactions during treatment with amiodarone hydrochloride. Brit Med J 287:175–180

    Article  CAS  Google Scholar 

  32. Morganroth J, Horowitz LN (1984) Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 53:89B-94B

    Article  PubMed  CAS  Google Scholar 

  33. Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RAJ, Camm AJ (1984) Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. Am Heart J 107:222–228

    Article  PubMed  CAS  Google Scholar 

  34. Winkle RA, Mason JW, Griffin JC, Ross D (1981) Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J 102:857–864

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiological Sciences, St George’s Hospital Medical School, Cranmer Terrace, London, SW17 ORE, UK

    A. John Camm & Nicholas J. Linker

Authors
  1. A. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas J. Linker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology-Angiology-Pneumology, University Hospital Ulm, Ulm, Germany

    V. Hombach

  2. Department of Cardiology - Angiology - Pneumology, University of Cologne, Cologne, Germany

    H. H. Hilger

  3. Division of Cardiology, St. Louis University, School of Medicine, St. Louis, Missouri, USA

    H. L. Kennedy

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Camm, A.J., Linker, N.J. (1989). Antiarrhythmic agents — 1987. In: Hombach, V., Hilger, H.H., Kennedy, H.L. (eds) Electrocardiography and Cardiac Drug Therapy. Developments in Cardiovascular Medicine, vol 92. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1081-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1081-2_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6976-2

  • Online ISBN: 978-94-009-1081-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation